RCKT – rocket pharmaceuticals, inc. (US:NASDAQ)

News

Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report? [Yahoo! Finance]
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "outperform" rating re-affirmed by analysts at William Blair.
Rocket Pharmaceuticals (NASDAQ:RCKT) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
EC grants orphan medicinal product status to Rocket's RP-A601 [Yahoo! Finance]
Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com